Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Arcturus Therapeutics Holdings Inc.

NASDAQ: ARCT · Life Sciences · 4 alerts · CIK 1768224

Share price
$8.31Close, Nov 16
Market cap
$240M
Shares outstanding
28.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Arcturus Therapeutics Holdings Inc. filings on SEC EDGAR ↗

4:21 PM ET 10-Q
Financial Results

Arcturus Therapeutics Holdings Q3 2026 Results: Net Loss of $7.41M, Loss Narrows

Arcturus Therapeutics reported a decrease in total assets from $271.1 million at the end of 2025 to $215.3 million as of September 30, 2026, primarily driven by a reduction in cash and cash equivalents. The company's forward-looking statements highlight the termination of the CSL Collaboration Agreement and plans to advance its therapeutics pipeline, including ARCT-810 and ARCT-032, independently or with other partners.

Key figure
Net loss $7.41M
4:07 PM ET 8-K
Financial Results

Arcturus Therapeutics Holdings Financial Results

Arcturus Therapeutics reported Q3 2026 financial results, ending the period with $281.3 million in cash and equivalents. The company highlighted pipeline progress, including the completion of the myNEO acquisition and plans to complete enrollment for its ARCT-032 Phase 2 cystic fibrosis study by year-end 2026.

Term
Q3 2026

“The third quarter marked a pivotal step forward for our liver therapeutics franchise, with encouraging ARCT-810 Phase 2 results and the introduction of LUNAR 2.0™, our next-generation mRNA delivery platform, which demonstrated a 38-fold improvement over the key lipid in ARCT-810 in non-human primates.”

Joseph Payne, President & CEO of Arcturus

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.